ESC 365 - Metabolomic profile of patients with new onset heart failure; more microvascular dysfunction in patients with preserved ejection fraction compared to reduced ejection fraction - the PREFERS Study

ESC Premium Access

Metabolomic profile of patients with new onset heart failure; more microvascular dysfunction in patients with preserved ejection fraction compared to reduced ejection fraction - the PREFERS Study

Session: Heart failure with preserved ejection fraction

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Associate Professor C. Hage (Stockholm, SE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Camilla Hage

Karolinska University Hospital, Stockholm (Sweden)

2 presentations

0 follower

4 more presentations in this session

State of the Art - Diagnosis of heart failure with preserved ejection fraction: What's new?

Speaker: Professor B. Pieske (Rostock, DE)

Different impact of muscle, fat, and bone mass in heart failure with reduced and preserved ejection fraction

Speaker: Doctor M. Konishi (Yokohama, JP)

Serum Trimethylamine N-Oxide levels and 16S rRNA gut microbiota profiling in patients with heart failure and preserved ejection fraction and healthy individuals

Speaker: Professor O. Drapkina (Moscow, RU)

Heart failure with preserved ejection fraction: how to further improve patient outcomes?

Speaker: Doctor M. Senni (Bergamo, IT)

Access the full session

Heart failure with preserved ejection fraction

Speakers: Associate Professor C. Hage, Professor B. Pieske, Doctor M. Konishi, Professor O. Drapkina, Doctor M. Senni

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources